Yes I agree, it's not the complete pasting we usually get from AFR.
Tribeca obviously don't cover MSB and have not drilled down into the other potential income streams of MSB's cells, completely different to Burman Invest ( Julia Lee ) who have allocated 6% the max for a spec share allowed in their fund.
Cheers BK14
Ann: EAP for Remestemcel-L in Children with MIS-C due to COVID-19, page-239
-
- There are more pages in this discussion • 187 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.0¢ |
Change
-0.025(2.51%) |
Mkt cap ! $1.107B | |||
| Open | High | Low | Value | Volume |
| 97.0¢ | $1.01 | 96.5¢ | $7.757M | 7.884M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 274918 | 97.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.5¢ | 974 | 1 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |